The Scripps Research Institute Expands New Board of Directors with the Appointment of Yucaipa Companies Founder and Philanthropist Ron Burkle

The Scripps Research Institute (TSRI), one of the world's largest, private, non-profit research organizations, this week announced the appointment of Ronald W. Burkle to its Board of Directors—adding another world-renowned business leader and philanthropist to its newly restructured board.

Burkle is Founder and Chairman of the Ronald W. Burkle Foundation, whose mission is to positively influence people around the world and their communities. He also founded The Yucaipa Companies, a premier investment firm that has established a record of fostering economic value through the growth, repositioning and responsible development of individual companies. He is widely recognized as one of America’s preeminent investors in the retail, distribution, technology, entertainment, sports and hospitality industries.

“Ron’s business acumen and philanthropic mindset will be critical to realizing the new self-sustaining ‘bench-to-bedside’ model we are building,” said Peter G. Schultz, Ph.D., President of TSRI and the California Institute for Biomedical Research (Calibr). “I am thrilled to welcome yet another incredibly credentialed individual to the TSRI board who can help guide our efforts to take on new challenges in advancing human health through basic science and drug discovery.”

In addition to his role as co-chairman of the Burkle Center for International Relations at the University of California, Los Angeles, Burkle is trustee of the Carter Center, the National Urban League and AIDS Project Los Angeles. He also has been an active member of the Frank Lloyd Wright Conservancy. Burkle has served as Chairman of the Board and controlling shareholder of numerous companies, including Soho House, Golden State Foods, Dominick's, Fred Meyer, Ralphs and Food4Less.

Send comments to: press[at]scripps.edu

“Ron’s business acumen and philanthropic mindset will be critical to realizing the new self-sustaining ‘bench-to-bedside’ model we are building.”
—Peter G. Schultz, Ph.D., President of TSRI and the California Institute for Biomedical Research (Calibr).

SEARCH NEWS & VIEWS

Researchers Discover a Signal Driving Type 1 Diabetes

Scientists Develop New Method to 'Fingerprint' HIV

The Scripps Research Institute Expands New Board of Directors with the Appointment of Yucaipa Companies Founder and Philanthropist Ron Burkle